Protein Detection Redefined

Proven. Compatible. Scalable Diagnostics.
Proven. Compatible. Scalable Diagnostics.
Proven. Compatible. Scalable Diagnostics.
Contact Us
What We Do

Protein Detection at Scale

AperionDx develops innovative diagnostic solutions that make protein detection more sensitive, more reliable*, faster and effortlessly scalable.
Powered by Protein-PCR™, our solutions work on the qPCR instruments you already own, transforming existing infrastructure into a global protein-measurement network with minimal setup, no new hardware, and easy rollout across single labs or multi-site programs.
*Validated against Simoa® and ELISA with PPA/NPA > 97.5% for Traumatic Brain Injury and Alzheimer's Disease under specified conditions.
Key Differentiators

Why Protein-PCR™?

ULTIMATE SENSITIVITY
Redefines the state-of-the-art sensitivity (LOD) for important TBI and AD protein biomarkers.
Comprehensive
Detects multiple key biomarkers in a single well via a cost-effective workflow.
Clinically Aligned
Designed to complement imaging and Cerebrospinal Fluid (CSF) assays for diagnostic accuracy and research insight.
ACCESSIBLE & SCALABLE
Runs on widely available qPCR systems; no proprietary hardware required.  Supports high-throughput testing in 96- or 384-well plates with less than 4-hour Turnaround Time.
Scalable
High-throughput testing for research and clinical settings with < 4-hour Turnaround Time.
How it Works

The Science Behind Protein-PCR™

Protein-PCR™ enables ultra-sensitive detection of disease biomarkers using standard qPCR instruments already present in laboratories worldwide. This innovation enables rapid, accessible, sensitive and scalable biomarker testing, delivering results in a few hours. Each assay is designed to maximize both operational simplicity as well as exquisite analytical sensitivity and specificity for its intended target analytes.
Learn More
Use Cases

Where Innovation Meets Impact

Research Labs
HOSPITALS & CLINICS*
*Pending regulatory review.
HOSPITALS & CLINICS*
*Pending regulatory review.
Biotech Companies
Drug Development
PHARMA INDUSTRY
Why We’re Here
We’re building
high-sensitivity,
precision diagnostics that are affordable, scalable, and clinically rigorous, so labs can detect and monitor disease faster. Research labs can probe with greater sensitivity. We pair Protein-PCR™ with the qPCR systems you already have to help your team move faster from question to answer, making high-quality testing more accessible and ultimately improving patient care.
Contact Us

Ready to Redefine Diagnostics?

Get in Touch